कृपया अन्य खोज का प्रयास करें
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s CELsignia diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Mothaffar F. Rimawi | - | 2019 | Member of Scientific Advisory Board |
Lee S. Schwartzberg | - | 2019 | Member of Scientific Advisory Board |
Richard E. Buller | 71 | 2019 | Independent Director |
Manfred Auer | - | - | Member of Scientific Advisory Board |
Mark D. Pegram | - | - | Member of Scientific Advisory Board |
Stanley M. Marks | 74 | - | Member of Scientific Advisory Board |
Adam M. Brufsky | - | - | Member of Scientific Advisory Board |
Lance G. Laing | 59 | 2012 | Co-Founder, Chief Science Officer, VP, Secretary & Director |
Brian F. Sullivan | 59 | 2012 | Co-Founder, Chairman & CEO |
Edward Greeno | - | - | Member of Scientific Advisory Board |
Richard J. Nigon | 74 | 2017 | Independent Director |
Carol Lange | - | - | Member of Scientific Advisory Board |
Ronald C. McGlennen | - | - | Member of Scientific Advisory Board |
Benita Katzenellenbogen | - | - | Member of Scientific Advisory Board |
Sara Hurvitz | - | - | Member of Scientific Advisory Board |
David F. Dalvey | 64 | 2014 | Independent Director |
John Katzenellengogen | - | - | Member of Scientific Advisory Board |
Leo T. Furcht | 75 | 2019 | Independent Director |
Ben Ho Park | - | 2020 | Member of Scientific Advisory Board |
Bora Lim | - | 2020 | Member of Scientific Advisory Board |
Hung Khong | - | 2021 | Member of Scientific Advisory Board |
Alberto Montero | - | 2021 | Member of Scientific Advisory Board |
Polly A. Murphy | 58 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है